Utility of B-type natriuretic peptide for predicting perioperative cardiovascular events in patients without history of cardiovascular disease undergoing major non-cardiac surgery

Korean Circulation Journal

Volumn 41, Issue 1, 2011, Pages 11-15

  Kim, Sung Eun ^a   Park, Dae Gyun ^a   Lee, Jun Hee ^a   Han, Kyoo Rok ^a   Oh, Dong Jin ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

B type natriuretic peptide; Cardiovascular disease; Perioperative care

Indexed keywords

NATRIURETIC PEPTIDE RECEPTOR B;

ADULT; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE INJURY; HEART SURGERY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD;

EID: 79952318022     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.1.11     Document Type: Article

References (23)

1. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845-50. (Pubitemid 8200494)
2. Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery: a multifactorial clinical risk index. Arch Intern Med 1986;146:2131-4.
3. Goldman L. Multifactorial index of cardiac risk in noncardiac surgery: ten-year status report. J Cardiothorac Anesth 1987;1:237-44.
4. Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT. Echocardiography for assessing cardiac risk in patients having noncardiac surgery: study of perioperative ischemia research group. Ann Intern Med 1996;125:433-41.
5. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002;105:1257-67.
6. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
7. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-63. (Pubitemid 38364624)
8. Choe HM, Yoo BS, Ryu HY, et al. The early changing pattern of the B-type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction. Korean Circ J 2006; 36:526-34.
9. Chung IH, Yoo BS, Ryu HY, et al. The relationship between the early follow-up BNP level and congestive status or prognosis in acute heart failure. Korean Circ J 2006;36:200-7.
10. Demellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006;92: 1645-50. (Pubitemid 44629177)
11. Feringa HH, Bax JJ, Elhendy A, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006;98:111-5. (Pubitemid 43902686)
12. Cuthbertson BH, Amin AR, Croal BL, et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events inpatients undergoing major non-cardiac surgery. Br J Anaesth 2007;99:170-6, (Pubitemid 47249387)
13. Cuthbertson BH, Card G, Croal BL, McNeilly J, Hillis GS. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 2007;62:875-81. (Pubitemid 47261789)
14. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007;94:903-9. (Pubitemid 47051217)
15. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. (Pubitemid 29416229)
16. Gilbert K, Larocque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med 2000;133:356-9.
17. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50:2357-68. (Pubitemid 50011582)
18. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiography predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation 1994;89:724-30. (Pubitemid 24056200)
19. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation 1995;92:835-41.
20. Laukkanen JA, Kurl S, Eranen J, Huttunen M, Salonen JT. Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med 2005;165:1788-93. (Pubitemid 41138969)
21. Bayes-Genis A, Vazquez R, Puig T, et al. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. Eur J Heart Fail 2007;9:802-7. (Pubitemid 47212830)
22. Miller JT, O'Rourke RA, Crawford MH. Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J 1988;116:1048-51.
23. Tsioufis C, Stougiannos P, Taxiarchou E, et al. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension. J Hypertens 2006;24:965-72. (Pubitemid 43670469)